Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

HONOLULU, Oct. 5, 2025 /PRNewswire/ — Disease-modifying treatments for movement disorders are scarce, but results from two ...

NIT Rourkela researchers developed an indigenous, low-cost force plate, making vital biomechanical diagnostic tools ...

Over the study period, individuals walking below the threshold exhibited greater deterioration in both motor and cognitive domains. Researchers in Turkey have observed that a 446-meter threshold on ...

A research team at the National Institute of Technology Rourkela (NIT Rourkela), led by Prof A Thirugnanam from the Department of Biotechnology and Medical Engineering, has developed an innovative, ...

On Sept. 19, a 10-year-old mare in Sanilac County, Michigan, tested positive for West Nile virus (WNV). The unvaccinated mare developed clinical signs on Sept. 6, including ataxia, gait changes, and ...

Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development. New ...

Recessive mutations in POLR3A exhibit considerable phenotypic diversity, spanning from severe childhood-onset hypomyelinating leukodystrophic syndrome to less severe gait disorders, which may present ...

“It’s called an ataxic gait,” Karen Coleman said, referring to the jerky, staggering walk she often sees in the cows she owns with her husband, Tony. The couple, who run a cattle operation on 315 ...

TAIPEI, March 26, 2025 /PRNewswire/ -- Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs, today announced the dosing of the first patient in the ...